OFS in Premenopausal Node+ Breast Cancer With Low Genomic Risk
Conditions
- Breast Cancer
- Estrogen Receptor Positive Tumor
- HER2-negative Breast Cancer
- Premenopausal Breast Cancer
- Node-positive Breast Cancer
Interventions
- DRUG: Ovarian function suppression with endocrine treatments
Sponsor
Gangnam Severance Hospital
Collaborators